News

Majority of CEOs Believe They Can Influence Hospital Practices to Reduce CIED Infections, Cost A new Medicare ruling that makes potentially avoidable surgical site infections (SSIs) following cardiac implantable electronic device (CIED)...

ARCA biopharma, Inc., a biopharmaceutical company developing genetically-targeted therapies for atrial fibrillation and other cardiovascular diseases, announced that the paper "Combinatorial pharmacogenetic interactions of bucindolol...

ClearSense Technology with unique three-vector design offers superior detection of arrhythmias and efficient implantation BIOTRONIK, a leading manufacturer of medical technology, announced the European market release of BioMonitor®, a unique...

September 2012: Oscor receives FDA, Canada and CE mark clearance on the next-generation steerable guiding sheath, the Destino. The Oscor Destino is the first and only steerable guiding sheath, which offers 180° bidirectional steering and is...

New technology reduces need for fluoroscopic images during cardiovascular procedures St. Jude Medical, Inc., a global medical device company, announced the launch of its MediGuide™ Technology, the first and only three-dimensional (3-D)...

Pending Addition of Next-Generation Mapping and Navigation System Would Expand Company Portfolio into Complex Electrophysiology Procedures Boston Scientific Corporation has entered into a definitive agreement to acquire privately-held...

First Enrolled Patient Safely Treated with Novel Technique at Prestigious Bordeaux Heart Center BioVentrix, the developer of minimally invasive therapies for the treatment of heart failure, announced the initiation of a Phase II clinical...

TYRX on Leading Edge of Medical Devices TYRX, Inc. announced that it has been named to the FierceMedicalDevices “Fierce 15” list, designating it as one of the leading medical device and diagnostic companies of 2012. FierceMedicalDevices...

BIOTRONIK renews commitment after achieving their first milestone of providing 1,000 life saving devices one year earlier than expected BIOTRONIK, a leading manufacturer of innovative medical technology, has surpassed its commitment to...

S-ICD System is the World's First and Only Commercially Available Completely Subcutaneous Implantable Defibrillator The U.S. Food and Drug Administration has granted Boston Scientific Corporation regulatory approval for its S-ICD® System,...